AOXG OTC
Aoxing Pharmaceutical Company, Inc.
1W: +0.0%
1M: +4.8%
3M: -46.3%
YTD: -62.7%
1Y: -68.6%
3Y: +120.0%
5Y: -85.0%
$0.00
+0.00 (+0.00%)
Weekly Expected Move ±60.0%
$-0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$56M
+6.0% ▲
5Y CAGR: -0.8%
Total Liabilities
$38M
-11.2% ▼
5Y CAGR: +13.6%
Shareholders Equity
$19M
+70.3% ▲
5Y CAGR: -13.2%
Cash & Investments
$7M
+28.7% ▲
5Y CAGR: +20.1%
Total Debt
$25M
-19.9% ▼
5Y CAGR: +15.4%
Net Debt
$19M
-29.8% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $4M | $4M | $2M | $5M | $7M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $4M | $4M | $2M | $5M | $7M |
| Net Receivables | $3M | $3M | $4M | $6M | $11M |
| Inventory | $2M | $3M | $2M | $3M | $3M |
| Other Current Assets | $0 | $0 | $0 | $0 | $0 |
| Total Current Assets | $10M | $12M | $11M | $21M | $27M |
| Property, Plant & Equip. | $27M | $27M | $26M | $29M | $26M |
| Goodwill & Intangibles | $8M | $607K | $546K | $485K | $2M |
| Long-Term Investments | $400K | $292K | $189K | $96K | $4K |
| Other Non-Current Assets | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Assets | $36M | $28M | $27M | $32M | $29M |
| Total Assets | $45M | $40M | $38M | $53M | $56M |
| — Liabilities — | |||||
| Accounts Payable | $3M | $3M | $4M | $4M | $3M |
| Short-Term Debt | $12M | $14M | $26M | $30M | $25M |
| Deferred Revenue | $323K | $516K | $733K | $291K | $414K |
| Other Current Liabilities | $599K | $4M | $1M | $802K | $2M |
| Total Current Liabilities | $19M | $22M | $34M | $41M | $38M |
| Long-Term Debt | $5M | $13M | $8M | $1M | $0 |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $5M | $13M | $8M | $2M | $340K |
| Total Liabilities | $24M | $35M | $42M | $43M | $38M |
| — Equity — | |||||
| Common Stock | $50K | $50K | $50K | $70K | $76K |
| Retained Earnings | -$39M | -$56M | -$64M | -$58M | -$56M |
| Accumulated OCI | $3M | $3M | $3M | $3M | $2M |
| Total Stockholders Equity | $22M | $6M | -$3M | $11M | $19M |
| Total Liabilities & Equity | $45M | $40M | $38M | $53M | $56M |
| — Key Metrics — | |||||
| Total Debt | $16M | $22M | $33M | $32M | $25M |
| Net Debt | $12M | $18M | $31M | $26M | $19M |
| Total Investments | $400K | $292K | $189K | $96K | $4K |